Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank description Gene Value Type Network Comparison Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 51 to 100 of 19268 in total
Value Type: Measured
\def\wcA{0.11111111111111\textwidth} \def\wcB{0.11111111111111\textwidth} \def\wcC{0.11111111111111\textwidth} \def\wcD{0.11111111111111\textwidth} \def\wcE{0.11111111111111\textwidth} \def\wcF{0.11111111111111\textwidth} \def\wcG{0.11111111111111\textwidth} \def\wcH{0.11111111111111\textwidth} \begin{longtable}{|c|c|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent Filtered\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \multirow{6}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 7\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent oxysterol binding protein-related protein 7 (osbp-related protein 7) (orp-7). [source:swissprot;acc:q9bzf2]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2113.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 736.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 2.86965\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent sedlin. [source:swissprot;acc:o14582]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 43\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 4300000\vspace{3pt}}\\\cline{2-2}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 339.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1153.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 3.39764\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent tbc1 domain family, member 8 (with gram domain); vascular rab-gap/tbc-containing. [source:refseq;acc:nm\_007063]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 2.31962\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 231962\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent vitelliform macular dystrophy 2-like protein 1. [source:refseq;acc:nm\_017682]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 43368.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 36360.3\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7008.5\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 277. [source:swissprot;acc:q9nrm2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 15605.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 13174.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 2430.4\vspace{3pt}}\\\cline{1-4}\cline{6-8} \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 8\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ba508n22.1 (hspc025) (fragment). [source:sptrembl;acc:q9hcw5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 6410\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 85\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 75.4118\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent db83 protein. [source:swissprot;acc:p57088]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 339.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1153.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 3.39764\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent deoxyribonuclease ii beta isoform 1 precursor; deoxyribonuclease ii beta; endonuclease dlad. [source:refseq;acc:nm\_021233]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 39358.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 33111.4\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 6246.7\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent nucleoporin nup43 (p42). [source:swissprot;acc:q8nfh3]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7500.75\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 5106.93\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 2393.82\vspace{3pt}}\\\cline{2-2}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 21185\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7307\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent phosphatidylinositol-glycan biosynthesis, class f protein (pig-f). [source:swissprot;acc:q07326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 5058.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 3278\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1.54317\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent synbindin (trs23 homolog) (hematopoietic stem/progenitor cell protein 172) (hspc172) (ptd009) (cgi-104). [source:swissprot;acc:q9y296]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 43\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 4300000\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 277. [source:swissprot;acc:q9nrm2]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 8770.72\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 7537.89\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1232.83\vspace{3pt}}\\\cline{1-2}\cline{4-4}\cline{6-8} \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent ataxin 2; olivopontocerebellar ataxia 2, autosomal dominant. [source:refseq;acc:nm\_002973]\vspace{3pt}}}&&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 14756\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 12478\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 2278\vspace{3pt}}\\\cline{4-4}\cline{6-8} &&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 11468.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 10255.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1212.6\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent ba508n22.1 (hspc025) (fragment). [source:sptrembl;acc:q9hcw5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 6410\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 85\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 75.4118\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent n33 protein. [source:swissprot;acc:q13454]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 5058.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 3278\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1.54317\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 21185\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7307\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent sperm associated antigen 7. [source:refseq;acc:nm\_004890]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 19280.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 23318\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 4037.2\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 1281.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 398.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 3.21581\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent ubiquitously transcribed y chromosome tetratricopeptide repeat protein (ubiquitously transcribed tpr protein on the y chromosome). [source:swissprot;acc:o14607]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 10.6048\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 383.762\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 36.1876\vspace{3pt}}\\\cline{1-3}\cline{6-8} \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 10\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 2804\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1593\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1211\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent implantation-associated protein. [source:refseq;acc:nm\_032121]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5058.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 3278\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1.54317\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent lipopolysaccharide-responsive and beige-like anchor protein (cdc4-like protein) (beige-like protein). [source:swissprot;acc:p50851]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 6410\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 85\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 75.4118\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 6193.07\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 7830.62\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1637.55\vspace{3pt}}\\\cline{2-2}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 21185\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7307\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 17265.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 19498.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 2232.7\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent serpin b12. [source:swissprot;acc:q96p63]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.56738\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 199.549\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 35.8425\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1281.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 398.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 3.21581\vspace{3pt}}\\\cline{1-3}\cline{5-8} \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 11\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 7252.02\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 5734.28\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1517.74\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 5341.81\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 4230.36\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1111.45\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent dab2 interacting protein; ngap-like protein; doc-2/dab2 interactive protein. [source:refseq;acc:nm\_032552]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1281.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 398.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 3.21581\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent hurpin (hacat uv-repressible serpin) (protease inhibitor 13) (headpin) (serpin b13). [source:swissprot;acc:q9uiv8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.71669\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 199.249\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 34.8539\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 21185\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7307\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent retinoblastoma-associated factor 600. [source:refseq;acc:nm\_020765]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 9368.87\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 7256.71\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 2112.16\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent serpin b12. [source:swissprot;acc:q96p63]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.56738\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 199.549\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 35.8425\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent thyroid receptor interacting protein 8 (trip-8) (fragment). [source:swissprot;acc:q15652]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2950.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1917.64\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1.53861\vspace{3pt}}\\\hline \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 12\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7099.51\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 5629.62\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1469.89\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent cytoplasmic polyadenylation element binding protein 4. [source:refseq;acc:nm\_030627]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 1281.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 398.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 3.21581\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 2954.24\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1921.96\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1.5371\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 17572.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 15464.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 2108.6\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent hurpin (hacat uv-repressible serpin) (protease inhibitor 13) (headpin) (serpin b13). [source:swissprot;acc:q9uiv8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.71669\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 199.249\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 34.8539\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 58\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 859\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 14.8103\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 40795.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 34190.9\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 6604.9\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent transcription initiation factor tfiid 135 kda subunit (tafii-135) (tafii135) (tafii-130) (tafii130). [source:swissprot;acc:o00268]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 30022.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 31122\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 1099.6\vspace{3pt}}\\\cline{1-4}\cline{6-8} \multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 13\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent adp-ribosylation factor gtpase-activating protein 3 (arf gap 3). [source:swissprot;acc:q9np61]\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent 1363\vspace{3pt}}}&\parbox{\wcH}{\vspace{3pt}\noindent 29\vspace{3pt}}\\\cline{3-3}\cline{8-8} &&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&&&&&\parbox{\wcH}{\vspace{3pt}\noindent 1316\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent cytoplasmic polyadenylation element binding protein 3. [source:refseq;acc:nm\_014912]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1281.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 398.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 3.21581\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent fk506-binding protein 6 (ec 5.2.1.8) (peptidyl-prolyl cis-trans isomerase) (ppiase) (rotamase) (36 kda fk506 binding protein) (fkbp- 36) (immunophilin fkbp36). [source:swissprot;acc:o75344]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 115.385\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 8.11997\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 14.21\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/